+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography



Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography



Echocardiography 35(2): 234-240



Survivors of childhood cancer treated with anthracyclines carry the risk for developing late-onset cardiotoxicity. The purpose of this study was to evaluate left ventricular (LV) function in this patient group and compare it with healthy controls by means of conventional and speckle tracking echocardiography (STE) after exposure to chemotherapy. Conventional and STE were performed in 45 childhood cancer survivors (mean age 11 ± 4.6; 26 male) treated with anthracyclines (median cumulative dosage 240 mg/m2 ; range, 100-460) and compared with age, gender and body surface area matched healthy controls. Follow-up period after chemotherapy was 21.9 ± 17.8 months. Blood samples were taken from survivors and controls to determine brain natriuretic peptide (BNP). Following anthracycline exposure, pediatric cancer survivors had lower longitudinal, radial anteroseptal, and radial anterior strain values compared to controls (P < .05). The calculated global longitudinal and global radial strain values were lower compared to the control group (P < .05). Both groups had normal ejection fraction (EF) and fractional shortening (FS). Brain natriuretic peptide (BNP) levels of both groups were in the normal range. Despite normal EF and FS, children exposed to anthracycline therapy may have late-onset subtle changes of LV strain values measured by STE. Whether these changes of strain can predict future risk of developing heart failure needs to be explored in further studies.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 060289297

Download citation: RISBibTeXText

PMID: 29106752

DOI: 10.1111/echo.13743


Related references

Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study. Heart 96(9): 701-707, 2010

Subclinical Anthracycline-Induced Cardiotoxicity in the Long - Term Follow-Up of Lymphoma Survivors: A Multi-Layer Speckle Tracking Analysis. Arquivos Brasileiros de Cardiologia 110(3): 219-228, 2018

Speckle tracking echocardiography predicts early subclinical anthracycline cardiotoxicity in patients with breast cancer. Journal of Clinical Ultrasound 45(4): 222-230, 2016

Two-dimensional speckle tracking echocardiography predicts early subclinical cardiotoxicity associated with anthracycline-trastuzumab chemotherapy in patients with breast cancer. Bmc Cancer 18(1): 1037, 2018

Head to head comparison of standard echo doppler and 3D speckle tracking echocardiography in detection of subclinical anthracycline cardiotoxicity in breast cancer. European Heart Journal 34(Suppl 1): 4575-4575, 2013

Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer. European Journal of Pediatrics 175(10): 1379-1386, 2017

Anthracycline cardiotoxicity in long-term survivors of childhood cancer. Cardiovascular Toxicology 7(2): 122-128, 2007

Impact of persistent left ventricular regional wall motion abnormalities in childhood cancer survivors after anthracycline therapy: Assessment of global left ventricular myocardial performance by 3D speckle-tracking echocardiography. Journal of Cardiology 70(4): 396-401, 2017

Early detection of anthracycline-induced cardiotoxicity using two-dimensional speckle tracking echocardiography. Cardiology Journal 20(6): 592-599, 2014

Left ventricular function assessed by two-dimensional speckle tracking echocardiography in long-term survivors of Hodgkin's lymphoma treated by mediastinal radiotherapy with or without anthracycline therapy. American Journal of Cardiology 107(3): 472-477, 2011

What is the Role of Two-Dimensional Speckle Tracking Echocardiography in the Diagnosis and Management of Anthracycline-Induced Cardiotoxicity?. Arquivos Brasileiros de Cardiologia 110(3): 229-230, 2018

Anthracycline cardiotoxicity in long-term survivors of childhood cancer: The light is not at the end of the tunnel. Pediatric Blood and Cancer 48(7): 649-650, 2007

Chemotherapy-Induced Cardiotoxicity: Subclinical Cardiac Dysfunction Evidence Using Speckle Tracking Echocardiography. Journal of Cardiovascular Echography 23(1): 33-38, 2013

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy. Pediatric Blood and Cancer 62(1): 123-127, 2015

Two-Dimensional Speckle Tracking Echocardiography Detects Subclinical Left Ventricular Systolic Dysfunction among Adult Survivors of Childhood, Adolescent, and Young Adult Cancer. Biomed Research International 2016: 9363951, 2016